期刊
CELL DEATH & DISEASE
卷 13, 期 12, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/s41419-022-05495-0
关键词
-
类别
资金
- Ministerio de Ciencia e Innovacion
- Agencia Estatal de Investigacion (AEI), through the Generacion de Conocimiento
- FEDER [PID2019-107213GB-I00, BFU2016-78154-R]
- EU's
- La Marato de TV3 [766214]
- ISCIII [201929-30]
- European Social Fund [PI18/00920, PI21/00789]
- [FL-M CD20/00191]
In non-small cell lung carcinoma, TRAIL death receptors autonomously regulate the expression and release of IL-8, contributing to a pro-tumorigenic inflammatory signature associated with NSCLC development and prognosis.
Interleukin-8 (IL-8/CXCL8) is a pro-angiogenic and pro-inflammatory chemokine that plays a role in cancer development. Non-small cell lung carcinoma (NSCLC) produces high amounts of IL-8, which is associated with poor prognosis and resistance to chemo-radio and immunotherapy. However, the signaling pathways that lead to IL-8 production in NSCLC are unresolved. Here, we show that expression and release of IL-8 are regulated autonomously by TRAIL death receptors in several squamous and adenocarcinoma NSCLC cell lines. NSCLC constitutively secrete IL-8, which could be further enhanced by glucose withdrawal or by treatment with TRAIL or TNF alpha. In A549 cells, constitutive and inducible IL-8 production was dependent on NF-kappa B and MEK/ERK MAP Kinases. DR4 and DR5, known regulators of these signaling pathways, participated in constitutive and glucose deprivation-induced IL-8 secretion. These receptors were mainly located intracellularly. While DR4 signaled through the NF-kappa B pathway, DR4 and DR5 both regulated the ERK-MAPK and Akt pathways. FADD, caspase-8, RIPK1, and TRADD also regulated IL-8. Analysis of mRNA expression data from patients indicated that IL-8 transcripts correlated with TRAIL, DR4, and DR5 expression levels. Furthermore, TRAIL receptor expression levels also correlated with markers of angiogenesis and neutrophil infiltration in lung squamous carcinoma and adenocarcinoma. Collectively, these data suggest that TRAIL receptor signaling contributes to a pro-tumorigenic inflammatory signature associated with NSCLC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据